# Actelis Networks Inc: financial statements, quarterly

ASNS · OTC · CIK 1141284 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asns.md) · [Financials](/companies/asns/financials.md) · [Filings](/companies/asns/filings.md) · [Insiders](/companies/asns/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/asns/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [845](/filings/0001213900-24-097877.md) | [1,017 d](/filings/0001013762-25-001251.md) | [726](/filings/0001213900-25-042679.md) | [3,431](/filings/0001213900-25-076747.md) | [2,541](/filings/0001213900-25-110375.md) | [1,062 d](/filings/0001213900-26-030942.md) | [721](/filings/0001213900-26-056772.md) | [941](/filings/0001213900-26-089172.md) | [643](/filings/0001213900-25-110375.md) | [1,366 d](/filings/0001213900-26-030942.md) | [958](/filings/0001213900-26-056772.md) | [1,132](/filings/0001213900-26-089172.md) |
| Cost of revenue | $k | [619](/filings/0001213900-24-097877.md) | [663 d](/filings/0001013762-25-001251.md) | [506](/filings/0001213900-25-042679.md) | [1,488](/filings/0001213900-25-076747.md) | [798](/filings/0001213900-25-110375.md) | [698 d](/filings/0001213900-26-030942.md) | [470](/filings/0001213900-26-056772.md) | [636](/filings/0001213900-26-089172.md) | [460](/filings/0001213900-25-110375.md) | [887 d](/filings/0001213900-26-030942.md) | [723](/filings/0001213900-26-056772.md) | [553](/filings/0001213900-26-089172.md) |
| Gross profit | $k | [226](/filings/0001213900-24-097877.md) | [354 d](/filings/0001013762-25-001251.md) | [220](/filings/0001213900-25-042679.md) | [1,943](/filings/0001213900-25-076747.md) | [1,743](/filings/0001213900-25-110375.md) | [364 d](/filings/0001213900-26-030942.md) | [251](/filings/0001213900-26-056772.md) | [305](/filings/0001213900-26-089172.md) | [183](/filings/0001213900-25-110375.md) | [479 d](/filings/0001213900-26-030942.md) | [235](/filings/0001213900-26-056772.md) | [579](/filings/0001213900-26-089172.md) |
| Research and development | $k | [691](/filings/0001213900-24-097877.md) | [585 d](/filings/0001013762-25-001251.md) | [647](/filings/0001213900-25-042679.md) | [603](/filings/0001213900-25-076747.md) | [543](/filings/0001213900-25-110375.md) | [590 d](/filings/0001213900-26-030942.md) | [681](/filings/0001213900-26-056772.md) | [675](/filings/0001213900-26-089172.md) | [591](/filings/0001213900-25-110375.md) | [691 d](/filings/0001213900-26-030942.md) | [689](/filings/0001213900-26-056772.md) | [658](/filings/0001213900-26-089172.md) |
| Operating income | $k | [(2,127)](/filings/0001213900-24-097877.md) | [(1,655) d](/filings/0001013762-25-001251.md) | [(1,871)](/filings/0001213900-25-042679.md) | [66.0](/filings/0001213900-25-076747.md) | [(317)](/filings/0001213900-25-110375.md) | [(1,635) d](/filings/0001213900-26-030942.md) | [(1,812)](/filings/0001213900-26-056772.md) | [(1,773)](/filings/0001213900-26-089172.md) | [(1,929)](/filings/0001213900-25-110375.md) | [(1,671) d](/filings/0001213900-26-030942.md) | [(1,863)](/filings/0001213900-26-056772.md) | [(1,582)](/filings/0001213900-26-089172.md) |
| Interest expense | $k | [161](/filings/0001213900-23-087004.md) | [(217) d](/filings/0001013762-25-001251.md) | [(61.0)](/filings/0001213900-24-043030.md) | [137](/filings/0001213900-25-076747.md) | [246](/filings/0001213900-25-110375.md) | [(35.0) d](/filings/0001013762-25-001251.md) | [34.0](/filings/0001213900-26-056772.md) | [22.0](/filings/0001213900-26-089172.md) | [27.0](/filings/0001213900-25-110375.md) | [168 d](/filings/0001213900-26-030942.md) | [14.0](/filings/0001213900-26-056772.md) | [106](/filings/0001213900-26-089172.md) |
| Net income | $k | [(867)](/filings/0001213900-24-097877.md) | [(1,931) d](/filings/0001013762-25-001251.md) | [(1,986)](/filings/0001213900-25-042679.md) | [(78.0)](/filings/0001213900-25-076747.md) | [(511)](/filings/0001213900-25-110375.md) | [(1,799) d](/filings/0001213900-26-030942.md) | [(1,860)](/filings/0001213900-26-056772.md) | [(1,901)](/filings/0001213900-26-089172.md) | [(1,980)](/filings/0001213900-25-110375.md) | [(2,520) d](/filings/0001213900-26-030942.md) | [(2,456)](/filings/0001213900-26-056772.md) | [(1,393)](/filings/0001213900-26-089172.md) |
| Diluted EPS | $ per share | [(0.32)](/filings/0001213900-24-097877.md) | not reported | [(0.50)](/filings/0001213900-25-042679.md) | [(0.01)](/filings/0001213900-25-076747.md) | [(0.09)](/filings/0001213900-25-110375.md) | not reported | [(2.18)](/filings/0001213900-26-056772.md) | [(2.08)](/filings/0001213900-26-089172.md) | [(0.17)](/filings/0001213900-25-110375.md) | not reported | [(0.16)](/filings/0001213900-26-056772.md) | [(0.05)](/filings/0001213900-26-089172.md) |
| Basic EPS | $ per share | [(0.32)](/filings/0001213900-24-097877.md) | not reported | [(0.50)](/filings/0001213900-25-042679.md) | [(0.01)](/filings/0001213900-25-076747.md) | [(0.09)](/filings/0001213900-25-110375.md) | not reported | [(2.18)](/filings/0001213900-26-056772.md) | [(2.08)](/filings/0001213900-26-089172.md) | [(0.17)](/filings/0001213900-25-110375.md) | not reported | [(0.16)](/filings/0001213900-26-056772.md) | [(0.05)](/filings/0001213900-26-089172.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-08-26) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.6](/filings/0001013762-25-001251.md) | [1.2](/filings/0001213900-25-042679.md) | [2.4](/filings/0001213900-25-076747.md) | [2.2](/filings/0001213900-25-110375.md) | [2.0](/filings/0001213900-26-030942.md) | [1.1](/filings/0001213900-26-056772.md) | [0.4](/filings/0001213900-26-089172.md) | not reported | [1.5](/filings/0001213900-25-110375.md) | [4.1](/filings/0001213900-26-089172.md) | [7.5](/filings/0001213900-26-056772.md) | [5.7](/filings/0001213900-26-089172.md) |
| Current assets | $m | [5.9](/filings/0001013762-25-001251.md) | [6.2](/filings/0001213900-24-043030.md) | [6.5](/filings/0001213900-24-069173.md) | [7.2](/filings/0001213900-24-097877.md) | [6.9](/filings/0001213900-26-030942.md) | [5.8](/filings/0001213900-25-042679.md) | [4.8](/filings/0001213900-25-076747.md) | not reported | [5.9](/filings/0001213900-25-110375.md) | [8.6](/filings/0001213900-26-089172.md) | [11.5](/filings/0001213900-26-056772.md) | [10.1](/filings/0001213900-26-089172.md) |
| Total assets | $m | [11.2](/filings/0001013762-25-001251.md) | [10.5](/filings/0001213900-24-043030.md) | [8.4](/filings/0001213900-24-069173.md) | [8.8](/filings/0001213900-24-097877.md) | [8.2](/filings/0001213900-26-030942.md) | [7.1](/filings/0001213900-25-042679.md) | [6.0](/filings/0001213900-25-076747.md) | not reported | [6.9](/filings/0001213900-25-110375.md) | [9.5](/filings/0001213900-26-089172.md) | [12.8](/filings/0001213900-26-056772.md) | [11.4](/filings/0001213900-26-089172.md) |
| Current liabilities | $m | [6.9](/filings/0001013762-25-001251.md) | [8.9](/filings/0001213900-24-043030.md) | [6.5](/filings/0001213900-24-069173.md) | [5.1](/filings/0001213900-24-097877.md) | [4.6](/filings/0001213900-26-030942.md) | [3.7](/filings/0001213900-25-042679.md) | [4.2](/filings/0001213900-25-076747.md) | not reported | [3.5](/filings/0001213900-25-110375.md) | [3.5](/filings/0001213900-26-089172.md) | [2.6](/filings/0001213900-26-056772.md) | [3.0](/filings/0001213900-26-089172.md) |
| Total liabilities | $m | [10.8](/filings/0001013762-25-001251.md) | [12.0](/filings/0001213900-24-043030.md) | [7.2](/filings/0001213900-24-069173.md) | [5.7](/filings/0001213900-24-097877.md) | [5.2](/filings/0001213900-26-030942.md) | [4.3](/filings/0001213900-25-042679.md) | [4.7](/filings/0001213900-25-076747.md) | not reported | [4.0](/filings/0001213900-25-110375.md) | [4.7](/filings/0001213900-26-089172.md) | [4.5](/filings/0001213900-26-056772.md) | [4.2](/filings/0001213900-26-089172.md) |
| Long-term debt | $m | [3.2](/filings/0001013762-25-001251.md) | [2.5](/filings/0001213900-24-043030.md) | [0.3](/filings/0001213900-24-069173.md) | [0.2](/filings/0001213900-24-097877.md) | [0.2](/filings/0001213900-26-030942.md) | [0.2](/filings/0001213900-25-042679.md) | [0.2](/filings/0001213900-25-076747.md) | not reported | [0.2](/filings/0001213900-25-110375.md) | [0.2](/filings/0001213900-26-089172.md) | [0.2](/filings/0001213900-26-056772.md) | [0.2](/filings/0001213900-26-089172.md) |
| Current portion of debt | $m | [1.3](/filings/0001013762-25-001251.md) | [1.1](/filings/0001213900-24-043030.md) | [0.5](/filings/0001213900-24-069173.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [0.6](/filings/0001213900-24-043030.md) | not reported | not reported | not reported | [0.1](/filings/0001213900-25-042679.md) | [0.3](/filings/0001213900-25-076747.md) | [0.4](/filings/0001213900-26-030942.md) | [0.4](/filings/0001213900-25-110375.md) | [0.4](/filings/0001213900-26-089172.md) | not reported | not reported |
| Shareholders' equity | $m | [0.4](/filings/0001213900-26-030942.md) | [(1.7)](/filings/0001213900-25-076747.md) | [1.1](/filings/0001213900-25-110375.md) | [3.1](/filings/0001213900-25-110375.md) | [3.0](/filings/0001213900-26-089172.md) | [2.8](/filings/0001213900-26-089172.md) | [1.3](/filings/0001213900-26-089172.md) | not reported | [3.0](/filings/0001213900-25-110375.md) | [4.8](/filings/0001213900-26-089172.md) | [8.3](/filings/0001213900-26-089172.md) | [7.2](/filings/0001213900-26-089172.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,255) d](/filings/0001213900-24-097877.md) | [(1,383) d](/filings/0001013762-25-001251.md) | [(203)](/filings/0001213900-25-042679.md) | [(2,140) d](/filings/0001213900-25-076747.md) | [(2,438) d](/filings/0001213900-25-110375.md) | [(1,768) d](/filings/0001213900-26-030942.md) | [(2,174)](/filings/0001213900-26-056772.md) | [(1,044) d](/filings/0001213900-26-089172.md) | [(2,419) d](/filings/0001213900-25-110375.md) | [(2,054) d](/filings/0001213900-26-030942.md) | [(1,902)](/filings/0001213900-26-056772.md) | [(1,736) d](/filings/0001213900-26-089172.md) |
| Capital expenditure | $k | [3.0 d](/filings/0001213900-24-097877.md) | [3.0 d](/filings/0001013762-25-001251.md) | [1.0](/filings/0001213900-25-042679.md) | [0.0 d](/filings/0001213900-24-069173.md) | [0.0 d](/filings/0001213900-25-110375.md) | [0.0 d](/filings/0001213900-26-030942.md) | not reported | not reported | [0.0 d](/filings/0001213900-25-110375.md) | [4.0 d](/filings/0001213900-26-030942.md) | [45.0](/filings/0001213900-26-056772.md) | [44.0 d](/filings/0001213900-26-089172.md) |
| Share repurchases | $k | [0.0 d](/filings/0001213900-24-097877.md) | [0.0 d](/filings/0001013762-25-001251.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1.7](/filings/0001213900-23-087004.md) | [1.7](/filings/0001213900-24-043030.md) | [2.3](/filings/0001213900-24-069173.md) | [2.7](/filings/0001213900-24-097877.md) | [4.0](/filings/0001213900-25-042679.md) | [4.3](/filings/0001213900-25-076747.md) | [6.0](/filings/0001213900-25-110375.md) | [0.9](/filings/0001213900-26-056772.md) | [0.9](/filings/0001213900-26-089172.md) | [11.8](/filings/0001213900-25-110375.md) | [15.6](/filings/0001213900-26-056772.md) | [25.8](/filings/0001213900-26-089172.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,837,580 at 2026-08-11, from the cover of the [10-Q filed 2026-08-13](/filings/0001213900-26-089172.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.